Conversion Labs closes $3.5M equity investment, submits application for Nasdaq listing

Conversion Labs (OTCQB:CVLB) announced an equity investment by a select group of private investors and family offices, including investors David Blitzer and Wes Edens, for $3.5M.

The company also submitted its application to list its common stock on Nasdaq.

The company’s annualized revenue run-rate recently exceeded $44M compared to $12.5M for all of 2019, driven by the increasingly popular proprietary brands and formulas that include Rex MD and Shapiro MD.

Read More Here...

Bookmark the permalink.

Comments are closed.